February 23, 2013 |
The World Baseball Classic has been far from a hit on American shores. Most fans cast their eyes a few weeks farther down the line to the start of the major-league season. Perhaps that could change this time around. After all, everyone loves some international intrigue. The Taiwanese baseball federation apologized to the South Korean federation earlier this week, according to South Korea's Yonhap News Agency. Why? Four Taiwanese scouts posed as umpires and snuck into a South Korean practice game on Tuesday.
January 13, 2013
From Frequent Flyers, the Daily News' Flyers blog: Flyers forward Tom Sestito enjoyed his time playing in England during the lockout. Except, you know, for the inedible food . . . and the fact that he came down with a case of the mumps. "They did the blood work and I ended up with a disease from the 1930s. I felt like I was on the Oregon Trail," Sestito said, laughing it off on Friday. "Turns out, a teammate's wife had it. I was already back in the U.S. for 6 days. I woke up one morning, my glands were all swollen, and I looked like 'Hitch.' [Will Smith in movie of the same name, not former coach Ken Hitchcock]
October 25, 2011 |
Five infants at the Cambridge School at Baldwin in Bryn Mawr have been diagnosed with chicken pox, the Montgomery County Health Department announced Tuesday afternoon. Harriet Morton, the department's spokeswoman, said the five cases were reported Monday. The report triggered a medical investigation that was ongoing Tuesday, Morton said. Because of the five cases, 11 other children at the school who were exposed to the sick infants, and had not vaccinated against the childhood illness, will be kept home from school, she said.
October 25, 2010 |
Who knows how these things spread? Maybe some of it is Twitter, some word of mouth, some the Internet, and some just plain old scouting and observation. However it happened, by the time ESPN the Magazine released its NBA preview edition, the majority of its experts - three out of four - had determined that 76ers rookie guard Evan Turner would be this season's "bust" pick. In a city waiting for a U-turn from its professional basketball team, and believing the No. 2 pick in the 2010 NBA draft would provide that much-needed redirection, the assessment of Turner as a bust is about as easy to swallow as a basketball.
October 20, 2006 |
Shares of Endo Pharmaceutical Holdings Inc. rose slightly yesterday despite a 33 percent decline in third-quarter profit attributed primarily to inventory de-stocking by a drug wholesaler. Analysts expected third-quarter earnings of 33 cents a share, but had anticipated revenue of $222.2 million - about $5 million more than the $217.1 million revenue reported. Endo attributed the lower profit and its 11 percent decline in third-quarter revenue primarily due to a major wholesaler's reducing excess inventory, and not to any reduced demand for its prescription drugs.
May 27, 2006 |
With a potential market of millions of aging Baby Boomers, Merck & Co. Inc. won federal approval yesterday to market the first shingles vaccine to people 60 and older. Shingles is the recurrence of the chicken-pox virus in adults, mostly elderly, and causes roughly one million new cases a year of blistering rashes and pain that can persist for weeks or years. The Food and Drug Administration approved the vaccine, which will be marketed under the brand name Zostavax. Zostavax, to be manufactured at Merck's complex in the Philadelphia suburbs, is an injected adult version of Merck's chicken-pox vaccine, and has been shown to prevent roughly half the outbreaks.
July 1, 2005 |
A booster dose of whooping-cough vaccine soon may be added to immunization shots for millions of American adolescents, at the urging yesterday of health experts. The 15-member advisory panel to the Centers for Disease Control and Prevention, however, rejected an additional chicken-pox booster for all young children and kept the total number of recommended shots at 25. The votes by the CDC's Advisory Committee on Immunization Practice, during a two-day meeting in Atlanta, was a setback for vaccine-maker Merck & Co. Inc., but a boost for GlaxoSmithKline P.L.C.
June 2, 2005 |
A new experimental vaccine cuts in half the chances of older people getting shingles, a blistering skin rash that can lead to months or years of intense pain. A study of more than 38,000 people age 60 or older found that those who received the vaccine, made by Merck & Co., were 51 percent less likely to develop shingles. The vaccine also reduced the severity of sickness in people who got shingles, and cut by two-thirds the chances of developing long-lasting nerve pain. If the vaccine wins approval from the Food and Drug Administration, its reach could be huge, considering that shingles affects at least one million Americans a year, according to the study in today's New England Journal of Medicine.
January 4, 2005 |
Nearly a decade after a new chicken pox vaccine began driving down the number of children getting the itchy red spots, the federal government now has an even more ambitious goal: to eliminate the disease from this country. But to help get there, it might mean giving children a second shot of the vaccine. That would be good news for the vaccine's maker, Merck & Co. But some doctors wonder if it would be worth the cost and effort of adding another shot in a crowded vaccination program.
August 27, 2004
At the Riverton Borough Council meeting Aug. 4, there was a discussion concerning the noise of the River Line horns at grade crossings. The discussion was prompted by a letter to former Mayor Bruce Gunn by U.S. Rep. Robert E. Andrews (D., N.J.). One of the more vocal members of the public suggested that we should sue NJ Transit for creating this noise problem. Gunn, now borough solicitor, suggested that we contact the chairman of the congressional committee that oversees the Federal Railroad Administration.